Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)
CUSIP: 413197104
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,644,670
- Total 13F shares
- 50,193,424
- Share change
- -2,940,598
- Total reported value
- $1,664,235,088
- Put/Call ratio
- 36%
- Price per share
- $33.19
- Number of holders
- 267
- Value change
- -$100,697,267
- Number of buys
- 133
- Number of sells
- 102
Quarterly Holders Quick Answers
What is CUSIP 413197104?
CUSIP 413197104 identifies HRMY - Harmony Biosciences Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 413197104:
Top shareholders of HRMY - Harmony Biosciences Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
10%
from 13D/G
|
6,968,097
|
$239,772,216 | — | 31 Dec 2024 | |
| Valor Management LLC |
13F
|
Company |
11%
|
6,618,033
|
$227,726,516 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
9.2%
|
5,329,902
|
$183,401,931 | — | 31 Dec 2024 | |
| Marshman Fund Trust II |
3/4/5
13D/G
|
10%+ Owner |
11%
from 13D/G
|
6,051,120
|
$183,364,064 | — | 01 Nov 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.2%
|
4,733,609
|
$162,883,485 | — | 31 Dec 2024 | |
| Pacer Advisors, Inc. |
13F
|
Company |
4%
|
2,279,918
|
$78,451,978 | — | 31 Dec 2024 | |
| Andreas Wicki |
3/4/5
|
Director |
—
class O/S missing
|
2,147,943
|
$71,655,378 | — | 12 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
1,580,815
|
$54,395,844 | — | 31 Dec 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
2.5%
|
1,450,000
|
$49,894,500 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.4%
|
1,368,232
|
$47,080,863 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.1%
|
1,213,029
|
$41,738,956 | — | 31 Dec 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.9%
|
1,102,604
|
$37,940,604 | — | 31 Dec 2024 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
1.7%
|
956,217
|
$32,903,000 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.6%
|
929,744
|
$31,992,490 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
902,934
|
$31,077,138 | — | 31 Dec 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.4%
|
829,620
|
$28,547,224 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
806,883
|
$27,764,858 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.99%
|
568,671
|
$19,567,969 | — | 31 Dec 2024 | |
| venBio Partners LLC |
13F
|
Company |
0.94%
|
539,194
|
$18,553,666 | — | 31 Dec 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.87%
|
500,000
|
$17,205,000 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.86%
|
495,048
|
$17,034,601 | — | 31 Dec 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.85%
|
492,803
|
$16,957,350 | — | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.83%
|
480,605
|
$16,537,618 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.82%
|
472,028
|
$16,242,483 | — | 31 Dec 2024 | |
| NORGES BANK |
13F
|
Company |
0.81%
|
468,410
|
$16,117,988 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.78%
|
449,180
|
$15,456,282 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.7%
|
404,462
|
$13,917,537 | — | 31 Dec 2024 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.64%
|
368,665
|
$12,685,763 | — | 31 Dec 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.62%
|
356,072
|
$12,252,438 | — | 31 Dec 2024 | |
| CAPITAL MANAGEMENT CORP /VA |
13F
|
Company |
0.59%
|
340,960
|
$11,732,434 | — | 31 Dec 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.54%
|
313,013
|
$10,770,777 | — | 31 Dec 2024 | |
| Cambria Investment Management, L.P. |
13F
|
Company |
0.54%
|
310,908
|
$10,698,344 | — | 31 Dec 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.53%
|
305,600
|
$10,515,696 | — | 31 Dec 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.52%
|
300,000
|
$10,323,000 | — | 31 Dec 2024 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.51%
|
296,618
|
$10,206,625 | — | 31 Dec 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.51%
|
291,550
|
$10,032,000 | — | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.49%
|
281,200
|
$9,676,092 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.48%
|
275,594
|
$9,483,190 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.46%
|
265,639
|
$9,140,652 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.41%
|
235,882
|
$8,116,700 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.41%
|
235,268
|
$8,095,572 | — | 31 Dec 2024 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.4%
|
230,908
|
$7,946,000 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.38%
|
221,063
|
$7,607,108 | — | 31 Dec 2024 | |
| Man Group plc |
13F
|
Company |
0.37%
|
214,113
|
$7,367,628 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.37%
|
212,351
|
$7,306,998 | — | 31 Dec 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.36%
|
208,663
|
$7,180,094 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.35%
|
202,508
|
$6,968,300 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.35%
|
199,801
|
$6,875,152 | — | 31 Dec 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.3%
|
175,574
|
$6,041,501 | — | 31 Dec 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.29%
|
169,409
|
$5,829,363 | — | 31 Dec 2024 |
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q1 2025
As of 31 Mar 2025,
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) was held by
267 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,193,424 shares.
The largest 10 holders included
Valor Management LLC, BlackRock, Inc., FMR LLC, VANGUARD GROUP INC, STATE STREET CORP, AMERICAN CENTURY COMPANIES INC, DIMENSIONAL FUND ADVISORS LP, LSV ASSET MANAGEMENT, GEODE CAPITAL MANAGEMENT, LLC, and MARSHALL WACE, LLP.
This page lists
271
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
244
Q1 2025 holders
267
Holder diff
23
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.